Efficacy and Safety of Biosimilar FYB201 Compared With Ranibizumab in Neovascular Age-Related Macular Degeneration

December 2022 Written by:  Jordan Deaner, MD Mid Atlantic Retina / Wills Eye Hospital Philadelphia, PA Holz FG, Oleksy P, Ricci F, et al. Efficacy and safety of biosimilar FYB201 compared with ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2022;129(1):54-63.   Recently the United States Food and Drug Administration (USFDA) approved the first interchangeable biosimilar for use […]

Laser Treatment after Minimized Eye Movement for Repair of Retinal Detachment

February 2022 Written by: Avni P. Finn, MDAssistant ProfessorVanderbilt Eye InstituteNashville, TN Kokame GT, Yee S, Omizo JN, Villanueva L, Liu J. Laser Treatment after Minimized Eye Movement for Repair of Retinal Detachment. Ophthalmol Retina. 2021 Sep;5(9):939-941. doi: 10.1016/j.oret.2021.01.014. Epub 2021 Jan 30. PMID: 33529816. Retinal detachment repair is typically performed via three potential procedures: […]

Telehealth-based Eye Care During the COVID-19 Pandemic: Utilization, Safety, and the Patient Experience

Written by: Jaya Badhwar Kumar, MDFlorida Retina InstituteOrlando, FL January 2022  Newman-Casey, Paula Anne et al. Telehealth-based Eye Care During the COVID-19 Pandemic: Utilization, Safety, and the Patient Experience. Am J Ophthal, 2021. 230: 234 –242. In the era of a global pandemic, the demand for telehealth services has expanded across all fields of medicine […]